Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - BeiGene, Ltd. | exhibit321-906cert.htm |
| EX-31.2 - EX-31.2 - BeiGene, Ltd. | exhibit312-302certcfo.htm |
| EX-31.1 - EX-31.1 - BeiGene, Ltd. | exhibit311-302certceo.htm |
| EX-23.1 - EX-23.1 - BeiGene, Ltd. | exhibit231-auditorsconsent.htm |
| EX-10.20 - EX-10.20 - BeiGene, Ltd. | exhibit1020-consultingagre.htm |
| EX-4.6 - EX-4.6 - BeiGene, Ltd. | exhibit46descriptionofsecu.htm |
| 10-K - 10-K - BeiGene, Ltd. | bgne-20201231.htm |
Exhibit 21.1
Subsidiaries
| Name of Subsidiary | Jurisdiction of Incorporation or Organization | Percentage of Ownership by the Registrant | ||||||||||||
| BeiGene 101 | Cayman Islands | 100 | % | |||||||||||
| BeiGene AUS Pty Ltd. | Australia | 100 | % | |||||||||||
| BeiGene (Beijing) Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
| BeiGene Biologics Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
| BeiGene (Canada) ULC | Canada | 100 | % | |||||||||||
| BeiGene ESP, S.L. | Spain | 100 | % | |||||||||||
| BeiGene France Sarl | France | 100 | % | |||||||||||
| BeiGene Germany GmbH | Germany | 100 | % | |||||||||||
| BeiGene Guangzhou Biologics Manufacturing Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
| BeiGene (Guangzhou) Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
| BeiGene (Hong Kong) Co., Limited | Hong Kong | 100 | % | |||||||||||
| Beijing Innerway Bio-tech Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
| BeiGene International GmbH | Switzerland | 100 | % | |||||||||||
| BeiGene Ireland Limited | Republic of Ireland | 100 | % | |||||||||||
| BeiGene (Italy) Sarl | Italy | 100 | % | |||||||||||
| BeiGene Japan, Ltd. | Japan | 100 | % | |||||||||||
| BeiGene Korea Y.H. | South Korea | 100 | % | |||||||||||
| BeiGene Netherlands B.V | Netherlands | 100 | % | |||||||||||
| BeiGene NZ, Limited | New Zealand | 100 | % | |||||||||||
| BeiGene Pharmaceuticals GmbH | Switzerland | 100 | % | |||||||||||
| BeiGene Pharmaceuticals (Guangzhou) Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
| BeiGene Pharmaceutical (Shanghai) Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
| BeiGene (Shanghai) Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
| BeiGene (Shanghai) Research & Development Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
| BeiGene Singapore Pte., Ltd. | Singapore | 100 | % | |||||||||||
| BeiGene (Suzhou) Co., Ltd. | People’s Republic of China | 100 | % | |||||||||||
| BeiGene Switzerland GmbH | Switzerland | 100 | % | |||||||||||
| BeiGene (Taiwan) Limited | Taiwan | 100 | % | |||||||||||
| BeiGene UK, Ltd. | United Kingdom | 100 | % | |||||||||||
| BeiGene United Kingdom, Ltd. | United Kingdom | 100 | % | |||||||||||
| BeiGene USA, Inc. | Delaware, United States | 100 | % | |||||||||||
| BeiGene US Holdings, LLC | Delaware, United States | 100 | % | |||||||||||
| BeiGene US Manufacturing Co., Inc. | Delaware, United States | 100 | % | |||||||||||